CDKN2B-AS1 and atherosclerosis: Expression data suggested a coordinated transcriptional regulation of ANRIL, CDKN2A and CDKN2B[47], and expression in tissues involved in atherosclerosis, like vascular endothelial cells, macrophages, and coronary smooth muscle cells, had been shown [40].